Corteva vs Nutrien
Nutrien reported revenue of $26.9 billion in fiscal 2025, 1.5 times Corteva's $17.4 billion in fiscal 2025. Corteva's revenue grew 2.9% in its latest year, and Nutrien's grew 3.5%. Free cash flow was $2.8 billion at Corteva and $2.1 billion at Nutrien.
Side by side
| Corteva | Nutrien | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $17.4B | $26.9B |
| Revenue growth | 2.9% | 3.5% |
| Revenue growth a year, last 5 years | 4.1% | 5.2% |
| Gross margin | 47.3% | 31.1% |
| Operating margin | — | 13.9% |
| Net margin | 6.3% | 8.4% |
| Free cash flow | $2.8B | $2.1B |
| Free cash flow margin | 16.2% | 7.9% |
| Return on capital | 5.8% | 8.0% |
| Net debt to EBITDA | −0.6x | 1.6x |
| Dividends and buybacks | $1.5B | $1.6B |
| Change in diluted share count | −2.1% | −1.6% |
| Last close | $11.95 | $68.22 |
| P/E at the last close | 7.9× | — |
| Insider trades, last 12 months | sold $636,213 | — |
| Piotroski F-score | 8 of 9 | 9 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CortevaNutrien
Operating margin
Percent of revenue
CortevaNutrien
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CortevaNutrien